CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203 | -99.5% | 13,631 | +0.7% | 0.00% | – |
| Q2 2022 | $40,000 | -68.0% | 13,535 | -66.4% | 0.00% | -100.0% |
| Q1 2022 | $125,000 | +4.2% | 40,225 | +13.3% | 0.00% | +100.0% |
| Q4 2021 | $120,000 | -4.0% | 35,495 | +23.6% | 0.00% | 0.0% |
| Q2 2021 | $125,000 | +54.3% | 28,719 | +61.9% | 0.00% | 0.0% |
| Q1 2021 | $81,000 | -44.1% | 17,739 | -11.2% | 0.00% | -66.7% |
| Q3 2020 | $145,000 | -54.8% | 19,971 | -78.3% | 0.00% | -62.5% |
| Q2 2020 | $321,000 | +146.9% | 91,992 | +407.1% | 0.01% | +60.0% |
| Q2 2019 | $130,000 | -81.9% | 18,142 | -66.4% | 0.01% | -90.6% |
| Q1 2019 | $717,000 | – | 54,003 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |